NEW YORK, June 5 - Genomics stocks jumped Tuesday, tagging along as investors drove up the Nasdaq by 3.6 percent and the Amex Biotechnology Index to a six-month high.

"Because Nasdaq is looking a little better, investors are looking [to be] a little more adventurous," said James Reddoch, an analyst at Banc of America Securities.

Some genomics companies won't be profitable for another four years, he added, but risk-tolerant investors are beginning to appreciate that a few companies "have a huge amount of value that is hard to quantitate."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.